Carlos Robles-Medranda, Raquel Del Valle, Miguel Puga-Tejada, Martha Arevalo-Mora, Domenica Cunto, Maria Egas-Izquierdo, Lorena Estrada-Guevara, Orlando Bunces-Orellana, Daniel Moreno-Zambrano, Juan Alcivar-Vasquez, Haydee Alvarado-Escobar, Ruxandra C Merfea, Jonathan Barreto-Perez, Jorge Rodriguez, Daniel Calle-Loffredo, Hannah Pitanga-Lukashok, Jorge Baquerizo-Burgos, Daniela Tabacelia
BACKGROUND: /aims: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has emerged as an alternative for the local treatment of unresectable pancreatic ductal adenocarcinoma (PDAC). We aim to assess the feasibility and safety of EUS-RFA in patients with unresectable PDAC. METHODS: The following was a historic cohort compounded by locally advanced (LA) and metastatic (m) PDAC naïve patients, who underwent EUS-RFA between October 2019 to March 2022...
March 20, 2024: Gastrointestinal Endoscopy